Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: The Wuhan Municipal Health Commission said seven other people were in critical condition among a total of 41 who were suffering from pneumonia caused by a "preliminarily determined new type of coronavirus" as of Friday. That was down from the earlier figure of 59. The others were in stable condition and at least two had been released from a hospital. The patient who died was identified as a 61-year-old man who had been hospitalized after suffering shortness of breath and severe pneumonia. The commission said the man, who died Thursday, also suffered from abdominal tumors and chronic liver disease and had been a frequent customer at a food market on Wuhan's outskirts linked to the majority of cases. China says the cause of the Wuhan outbreak remains unknown, but has sought to quash speculation that it could be a reappearance of the SARS epidemic, which killed hundreds in 2002 and 2003. Coronaviruses are a large family of viruses, some of which cause the common cold. Others found in bats, camels and other animals have evolved into more severe illnesses. Common symptoms include a runny nose, headache, cough and fever. Shortness of breath, chills and body aches are associated with more dangerous kinds of coronaviruses, according to the U.S. Centers for Disease Control and Prevention. China's transport ministry says it plans additional measures to disinfect trains, planes and buses and prevent transmission of diseases during the 40-day travel rush centered on the Lunar New Year, also known as the Spring Festival, which falls this year on Jan. 25. The period began Friday and runs through Feb. 18. "The emergence of the epidemic may cause panic among people, especially in areas where people are concentrated during the Spring Festival travel period," the ministry's chief engineer, Wang Yang, told reporters at a news conference Thursday. "In order to further ensure the health of passengers, our ministry attaches great importance to the arrangements and deployment, and will focus on the disinfection monitoring and protection measures in areas with a large number of passenger travel volume, including transportation hubs, passenger stations and cargo hub plant stations," Wang said. Possible cases of the same illness have been reported in Hong Kong, South Korea and Taiwan involving recent travelers to Wuhan. Health authorities elsewhere in China have yet to announce similar cases, despite the high population density around Wuhan and its role as a travel hub for central China. University of Hong Kong disease expert Yuen Kwok-yung was quoted by the city's official news agency as saying that the genetic makeup of the novel coronavirus was 80% similar to SARS as it had been found in bats, civet cats and humans. Yuen said that it was unclear whether the virus could further change to become more lethal, as the SARS virus had, but that Hong Kong had a robust system for detecting more severe problems among patients. "So we have to take every measure and closely monitor the situation," Yuen said, according to Radio Television Hong Kong. Claim: China reports 1st death from new type of coronavirus .

Output: Health authorities in a central Chinese city on Saturday reported the country's first death from a new type of coronavirus, as the government braced for the Lunar New Year travel boom amid concerns over a possible outbreak similar to that of the SARS virus in the early 2000s.

Input: Consider Input: Paragraph: The 10,000 or so people who remain on Ambae island have mixed feelings about the plans. Some who are badly affected by the ash are eager to leave while others are resisting losing their land and culture. The island was temporarily evacuated last September when the eruption cycle began. This time, authorities are planning a permanent move. Government spokesman Hilaire Bule told The Associated Press on Thursday that he expects the Council of Ministers to approve a relocation plan by next week. Bule said the islanders would be offered residence on two neighboring islands. "It's not an easy decision," Bule said. He said there were many details to work through, including providing schools and facilities to the displaced residents and negotiating land and new homes for them. Many people have close family and spiritual ties to the islands where they'll be relocated, Maewo and Pentecost, Bule said. Traditional religion even has it that the islands are part of a family Pentecost being the mother, Maewo the father and Ambae the son. Most people on Ambae live a subsistence lifestyle by farming and fishing. Already hundreds of people have moved to temporary shelters on parts of the island that are not so affected by the ash. Ambae is about 400 square kilometers (154 square miles) and is one of about 65 inhabited islands in Vanuatu, which is home to 280,000 people. Vanuatu sits on the Pacific's "Ring of Fire," the arc of seismic faults around the Pacific Ocean where earthquakes and volcanoes are common. Brad Scott, a New Zealand volcanologist with GNS Science who has been seconded to help Vanuatu authorities, said more than one-quarter of Ambae has been severely impacted, with many traditional thatch roofs collapsing under the weight of the thick ash. He said traditional gardens have been buried and killed in some places and water supplies have been discolored and the water tastes strange. He said there is lots of fine-grained ash, which can affect people's breathing and respiratory functioning. Other countries including France, New Zealand and Australia provided aid and financial help for the earlier evacuation. Australia on Thursday announced it was providing 300,000 Australian dollars ($226,000) to help with the island's permanent evacuation, with a focus on the needs of women, children and people with disabilities. Despite the problems, Scott said, many people want to stay put. "There has been significant pushback in the community," Scott said. "Some people, suffering from significant ash fall, would love to be anywhere else on the planet. Others have strong cultural associations." Scott said the Manaro volcano on Ambae island had a large eruption about 400 years ago and has had several smaller eruptions over the past 100 years. There have been three phases in the current eruption, with the most recent phase, which started in March, producing the most ash. He said the volcano has actually quietened down over the past two weeks, although there is no way of predicting if and when the next explosive phase would begin. Asked if there was a chance that the residents might be able to one day move back to the island, Bule, the government spokesman, said that was not a question for him. "We don't know," he said. "You'll have to ask the volcano." Claim: Vanuatu plans to permanently evacuate entire volcanic island.

Output: The Pacific nation of Vanuatu is preparing to permanently evacuate the entire population of one of its islands as thick ash spewing from a volcano kills crops, dirties water supplies and fouls the air.

Input: Consider Input: Paragraph: Some legal experts believe Bayer will have a tough time convincing appellate courts to throw out verdicts and lawsuits on those grounds. Bayer has a better shot if a business-friendly U.S. Supreme Court takes up the case, experts said. But that could take years. Bayer has come under intensifying pressure after a third consecutive U.S. jury on Monday found Roundup to be carcinogenic, awarding more than $2 billion to a couple who used the chemical on their property - the largest verdict in the glyphosate litigation to date. Bayer, which inherited the Roundup litigation with its $63 billion acquisition of Monsanto last year, faces lawsuits by more than 13,400 plaintiffs nationwide, alleging the product causes cancer. The Germany-based company's shares have been hammered since the first Roundup cancer verdict against it last August, wiping out some 40 billion euros ($44.76 billion) in market value and leaving Bayer worth less than the price it paid for Monsanto. Bayer denies that Roundup causes cancer, saying decades of studies have shown glyphosate and the weed killer to be safe. On Wednesday, the company said it will argue that the lawsuits, which are brought under state law, conflict with guidance from a federal agency, the U.S. Environmental Protection Agency. On April 30, the EPA reaffirmed prior guidance saying that glyphosate is not a carcinogen and not a risk to public health when used in accordance with its current label.. Citing the EPA decision, Bayer has repeatedly rebuked plaintiffs' calls to add a cancer warning to Roundup, saying the agency would reject that change. Under the legal doctrine of preemption, state law claims are barred if they conflict with federal law. "We have very strong arguments that the claims here are preempted ... and the recent EPA registration decision is an important aspect of that defense," William Hoffman, one of Bayer's lawyers, said during a call with reporters on Wednesday. Hoffman said the argument applied to all U.S. Roundup lawsuits. Preemption is generally regarded as a "silver bullet defense" because it stops claims across the board, said Adam Zimmerman, a law professor at Loyola Law School in Los Angeles. But Zimmerman and three other legal experts agreed that Bayer faces a big hurdle convincing appeals courts that the EPA determination on glyphosate shields it from state law claims. They cited a 2005 U.S. Supreme Court ruling that the EPA's approval of a product does not necessarily bar state law claims. The ruling, Bates v Dow Agrosciences, gives broad leeway to juries to decide if such claims should proceed, they said. Judges in the three Roundup cases that have gone to trial against Monsanto all rejected the company's preemption argument, citing this ruling. "In light of the Bates decision, it's going to be an uphill battle for the company to win on preemption on appeal," Zimmerman said. Bayer also said it will argue on appeal that trial courts improperly admitted evidence that was not backed up by science. But legal experts said appellate courts generally defer to lower court evidentiary rulings. Lars Noah, a law professor at the University of Florida, said Bayer's chances of success would increase significantly if the Supreme Court takes up the Roundup appeals. The high court only accepts around 70 cases each year, but a business-friendly majority on the court could be inclined to hear the dispute, said Alexandra Lahav, a law professor at the University of Connecticut. Since 2005, the high court has decided at least three preemption cases in favor of companies, none of which involved the EPA. The Supreme Court will soon rule in another case that rests on whether a U.S. Food and Drug Administration approval preempts tort claims. In that case, plaintiffs sued Merck & Co over the company's alleged failure to warn of the risk of serious bone fractures associated with its osteoporosis drug Fosamax. Merck, which denies the allegations, argued the lawsuits should be preempted because the FDA did not require an additional fracture warning in the drug's prescribing information. During a January hearing, the Justices appeared to side with the company. Bayer in a statement on Thursday said it does not believe the 2005 Bates ruling posed a barrier for the appellate courts due to other Supreme Court rulings since then. Noah agreed that the Court has more recently signaled its appetite to limit lawsuits that contradict opinions by experts at regulatory agencies. "The Bates decision by now sticks out like a sore thumb," Noah said. "Bayer has more than enough ammunition in recent Supreme Court cases to show the trial court judges got it wrong." Claim: Bayer bets on 'silver bullet' defense in Roundup litigation; experts see hurdles.
Output: Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be tossed because a U.S. regulatory agency said the herbicide is not a public health risk.